Gyre Therapeutics's total assets for Q1 2026 were $162.01M, a decrease of -2.48% from the previous quarter. GYRE total liabilities were $25.03M for the fiscal quarter, a 4.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.